Cargando…
T Lymphocytes as Targets for SARS-CoV-2
Despite numerous data on the absence or weak expression of the main functional receptor of SARS-CoV-2 angiotensin-converting enzyme 2 (ACE2) by T cells, it was recently demonstrated that the new coronavirus can efficiently infect T lymphocytes. Here, we analyze the data on the alternative (ACE2-inde...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201263/ https://www.ncbi.nlm.nih.gov/pubmed/35790412 http://dx.doi.org/10.1134/S0006297922060086 |
_version_ | 1784728270367883264 |
---|---|
author | Kuklina, Elena M. |
author_facet | Kuklina, Elena M. |
author_sort | Kuklina, Elena M. |
collection | PubMed |
description | Despite numerous data on the absence or weak expression of the main functional receptor of SARS-CoV-2 angiotensin-converting enzyme 2 (ACE2) by T cells, it was recently demonstrated that the new coronavirus can efficiently infect T lymphocytes. Here, we analyze the data on the alternative (ACE2-independent) pathways of cell infection, identified T cell subpopulations that serve as the most plausible targets of SARS-CoV-2, discuss the mechanisms of virus–cell interaction, including both infectious and non-infectious pathways of T lymphocyte regulation, and estimate the role of the virus-dependent damage of T lymphocytes in COVID-19 pathogenesis. Particular attention is paid to regulatory T cells as potential targets of SARS-CoV-2, as well as to the possible involvement of exosomes in the sensitivity of peripheral T cells to the virus. |
format | Online Article Text |
id | pubmed-9201263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Pleiades Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-92012632022-06-17 T Lymphocytes as Targets for SARS-CoV-2 Kuklina, Elena M. Biochemistry (Mosc) Review Despite numerous data on the absence or weak expression of the main functional receptor of SARS-CoV-2 angiotensin-converting enzyme 2 (ACE2) by T cells, it was recently demonstrated that the new coronavirus can efficiently infect T lymphocytes. Here, we analyze the data on the alternative (ACE2-independent) pathways of cell infection, identified T cell subpopulations that serve as the most plausible targets of SARS-CoV-2, discuss the mechanisms of virus–cell interaction, including both infectious and non-infectious pathways of T lymphocyte regulation, and estimate the role of the virus-dependent damage of T lymphocytes in COVID-19 pathogenesis. Particular attention is paid to regulatory T cells as potential targets of SARS-CoV-2, as well as to the possible involvement of exosomes in the sensitivity of peripheral T cells to the virus. Pleiades Publishing 2022-06-16 2022 /pmc/articles/PMC9201263/ /pubmed/35790412 http://dx.doi.org/10.1134/S0006297922060086 Text en © Pleiades Publishing, Ltd. 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Kuklina, Elena M. T Lymphocytes as Targets for SARS-CoV-2 |
title | T Lymphocytes as Targets for SARS-CoV-2 |
title_full | T Lymphocytes as Targets for SARS-CoV-2 |
title_fullStr | T Lymphocytes as Targets for SARS-CoV-2 |
title_full_unstemmed | T Lymphocytes as Targets for SARS-CoV-2 |
title_short | T Lymphocytes as Targets for SARS-CoV-2 |
title_sort | t lymphocytes as targets for sars-cov-2 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201263/ https://www.ncbi.nlm.nih.gov/pubmed/35790412 http://dx.doi.org/10.1134/S0006297922060086 |
work_keys_str_mv | AT kuklinaelenam tlymphocytesastargetsforsarscov2 |